BDBM590772 6-(2,3-dihydrobenzo[b][1,4]dioxin-6- yl)-4-hydroxy-N-(4-methylcyclohexyl)-1-(2- morpholinoethyl)-2-oxo-1,2-dihydro- 1,8-naphthyridine-3-carboxamide::US11564928, Compound 19

SMILES CC1CCC(CC1)NC(=O)c1c(O)c2cc(cnc2n(CCN2CCOCC2)c1=O)-c1ccc2OCCOc2c1

InChI Key InChIKey=LHDXGRHFEPNWGB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590772   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590772(US11564928, Compound 19 | 6-(2,3-dihydrobenzo[b][1...)
Affinity DataIC50: 20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590772(US11564928, Compound 19 | 6-(2,3-dihydrobenzo[b][1...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent